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Some viruses and bacteria can survive freezing for thousands of years. Permafrost
(ground with a temperature of or below 0°C for at least two consecutive years) covers
25% of the Northern Hemisphere. Whilst permafrost has persisted for millions of
years, it is now thawing rapidly because of global warming. When permafrost thaws,
microorganisms that were previously dormant can be released and become active.
Some microorganisms may be pathogens, which can infect and potentially cause
severe disease in humans, animals, and plants with major impacts on public health,
socioeconomic wellbeing, and natural ecosystems. Global warming and increased
disturbance of permafrost from human activities in the Arctic Circle are raising the
likelihood of future localised outbreaks, or even pandemics, from dormant pathogens
hidden in these frozen soils. This article provides a background to the risks associated
with the release of pathogens from permafrost, how these risks can be minimised,
and the implications for policy and international cooperation in light of the Covid-19
pandemic.
Science ⇒ Policy
Global warming is increasing the chance that disease-causing microbes will emerge
from frozen soils called permafrost. Thawing permafrost releases dormant viruses
and bacteria which can cause serious disease outbreaks. Global cooperation and
surveillance at sites of mass graves and past outbreaks are needed to manage this
threat to public health.
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Background
The Covid-19 pandemic demonstrates the ex-
treme risk posed by novel pathogens to human
civilisation and the global need to take the risk
of future pandemics more seriously. The SARS-
CoV-2 virus is thought to have been transmitted
to humans in an animal market and ultimately
from natural reservoirs of various pathogens that
circulate within different animal populations [1–
3]. A less commonly recognised source of novel
pathogens comes from an unlikely source: per-
mafrost [4–7].
Permafrost is defined as any ground that exists at
a temperature of or below 0°C for at least two con-
secutive years [8]. It typically consists of soil held
together by ice; this unique environment may har-
bour novel pathogens that have effectively been
frozen in time. Permafrost underlies a substan-
tial proportion of the Earth’s surface: 25% of
the Northern Hemisphere and 17% of the Earth’s
exposed land surface [9]. Given its temperature-
based definition, this permafrost layer is highly
susceptible to global warming caused by climate
change, which may expose much of its organic
contents [8, 10–15]. Portions of the permafrost
routinely thaw each summer, but permafrost has
warmed globally by 0.29◦C (+-0.12) from 2007-
2016 [8] and it is expected that ancient permafrost
layers buried deeper in the ground will continue
to be exposed.
Pathogens, such as viruses and bacteria, are
thought to be able to survive in frozen condi-
tions for thousands of years [5] and have been
detected in permafrost by scientists since the late
nineteenth century [4, 6, 16]. Therefore, the risk
that such pathogens could be exposed by thawing
permafrost as global warming increases temper-
atures in the polar regions is a serious one [7]:
particularly because the Arctic Circle is warming
approximately three times faster than the rest
of the world [17, 18]. This issue was highlighted
by a recent Horizon Scan for biodiversity conser-
vation in 2018 [19]. Given the clear and present
dangers of novel pathogens to public health, it
is important that the risk posed by pathogens in
permafrost is explored in more detail.
Previous evidence of permafrost-
related pathogen transmission
and infection
A BBC Earth article [20] reported on the most
recent (at time of writing) and widely acknowl-
edged transmission of a pathogen originating in
the permafrost to animals and humans. In Au-
gust 2016, in a remote area of the Siberian tundra
called the Yamal Peninsula in the Arctic Circle,
a 12-year-old boy died and at least twenty people
were hospitalised after being exposed to Bacil-
lus anthracis, the agent of anthrax, a common
disease of livestock and occasionally of humans
[20, 21]. The source was traced back to a carcass
of a reindeer that had perished 75 years before.
Thawing permafrost had exposed the carcass, re-
leasing infectious B.anthracis spores into the wa-
ter, soil, and ultimately the local food supply
[20, 22]. Records also show that from 1897-1925,
approximately 1.5 million deer died from anthrax
in Northern Russia and currently lie buried in
shallow graves due to the difficulty of digging in
the tundra soils [6]. Anthrax in humans have
been reported in 29,000 settlements in Northern
Russia located near burial grounds of cattle that
succumbed to anthrax in the past, including over
200 in settlements of the Yakutia people [6]. The
threat of the re-emergence of anthrax spores re-
mains a real and present danger given that they
have been shown to remain viable for 105 years
in permafrost [23] Whilst anthrax is a serious
infectious disease that causes severe illness, it is
spread by spores and is not contagious [21]. It is
therefore highly unlikely to cause pandemics on
the scale of the recent Covid-19 pandemic, but
most probably acute, local outbreaks of disease.
More concerning is the identification of
pathogenic materials in the permafrost, such as
fragments of RNA (ribonucleic acid – the genetic
material of certain viruses) from the 1918 Span-
ish influenza virus in corpses from mass graves
in the tundra of Alaska [24]. Fragments of viral
DNA from the variola or Smallpox virus were also
detected in frozen mummies unearthed in Siberia,
which also had visible Smallpox-like spores [25].
Although these were only degraded fragments,
it is possible that intact viruses, such as Small-
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pox and other viruses that have caused past pan-
demics including the bubonic plague, are buried
in mass graves [6]. The most likely viruses to per-
sist in the permafrost are so-called ’giant viruses’
that resist many of the pressures that burst open
smaller viruses due to their rugged outer shells
[16]. For example, a Pithovirus capable of repli-
cating itself was found in 30,000-year-old thawed
permafrost in Siberia (although typically only
infects amoebas) [26], whilst 5,000-year-old cari-
bou faeces was also found to contain viable virus
particles [27].
Although the risk of human infection by viral
pathogens hidden within the permafrost is fairly
low, there are many unknowns surrounding the
level of infectiousness or the disease severity asso-
ciated with such viruses. Therefore, assessing dif-
ferent risk-based scenarios is important, including
the worst-case scenario in which a highly infec-
tious virus is released, against which most people
will lack prior immunity or even cross-reactive
protection from current antibodies [28].
It is also possible that fungi, another type
of pathogen, are harboured in the permafrost.
Whilst most fungal species have beneficial im-
pacts (e.g., through contributing essential ecosys-
tem services such as supporting crop production
[29–31]), pathogenic fungi can have major neg-
ative impacts on human health (particularly of
immunosuppressed people). Fungal pathogens
also threaten wider society by infecting trees and
impacting forestry production, or by infecting
crops and harming global food security [32–34].
However, diseases caused by fungal species are not
thought to be contagious and so have a limited
potential to cause pandemics [28]. Nevertheless,
the growing interconnectedness of world trade
and travel means that the potential for fungal
pathogens to impact forestry and crop produc-
tion is a major concern (e.g., as illustrated by the
spread of Hymenoscyphus fraxineus, the cause of
ash dieback, across Europe; [35, 36]).
The most likely types of pathogens that would
be able to survive in permafrost, and therefore
arguably pose the greatest risk, are those that
can form spores (e.g., fungal pathogens, Anthrax-
causing bacterium B.anthracis, and species of
Clostridium bacteria that cause tetanus and bo-
tulism; C.tetani and C.botulinum, respectively
[4, 7, 28, 32]). Given antibiotics are likely to
be the main line of defence against infection by
spore-forming bacteria, we must carefully con-
sider whether bacteria from permafrost can be
effectively treated with current antibiotics. An-
tibiotic or antimicrobial resistance is a major
growing concern for public health globally, as
more and more bacteria evolve to survive expo-
sure to multiple drugs, rendering conventional
medical treatments less effective [37, 38]. It is
dangerous to assume that bacteria lying dormant
in permafrost have not yet evolved resistance to
current antibiotics, since research has suggested
that some bacteria, isolated in caves for tens of
thousands of years, demonstrated resistance to
over 18 modern antibiotics – most likely gained
through competition with fungi that naturally
produce antibiotics [39].
Future risks and policy implica-
tions
Whilst the current likelihood of the release of a
contagious pathogen from permafrost is likely to
be low at present, the current Covid-19 pandemic
demonstrates the need to take the risk of such an
occurrence seriously. Increasing levels of human
contact with thawing permafrost directly driven
by climate change, as well as increased oil, gas,
and mineral extraction in the Arctic circle, will
only increase the chance of pathogens being re-
leased from thawing permafrost. In particular,
the evidence suggests that the likelihood of lo-
calised outbreaks due to spore-driven pathogens,
that cause diseases such as Anthrax, is at least
moderate and should be taken extremely seri-
ously.
However, with increased preparedness, moni-
toring, and surveillance, the threat from such
pathogens could be minimised to a great extent.
For example, pre-emptive monitoring and surveil-
lance to detect Anthrax outbreaks should be tar-
geted towards the 13,885 cattle burial grounds
scattered across northern Russia [6, 28], whilst
local and historical records can be used to identify
more high-risk sites in other parts of the Arctic
Circle (e.g., in Scandinavia and North America).
The same approach is also likely to be useful
for identifying old sites of mass graves for the
bubonic plague and Spanish flu using historical
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records. Early monitoring and surveillance in
high-risk areas could catch dangerous pathogens
before they become a serious problem.
Such monitoring and surveillance should also con-
sider human exploitation of the Arctic Circle for
oil, gas, and mineral extraction, which may lead
to novel pathogen exposure events. Organisations
need to acknowledge the biosecurity risks involved
in undertaking these activities and ensure adher-
ence to strict biosecurity protocols, so that risk is
minimised for humans in contact with permafrost
soils. Ultimately, to ensure organisations are held
accountable for their actions, local and interna-
tional laws may need to be considered to regulate
activities in the Arctic Circle from a biosecurity
perspective [40–42].
Effective surveillance and monitoring for potential
outbreaks will require strong cooperation between
local and international public health organisations
(such as the World Health Organisation (WHO)),
and between governments of countries where most
of the Northern Hemisphere’s permafrost exists
(i.e., the USA, Canada, Russia, Norway, Finland,
and Sweden [40–42]). Whilst such cooperation
may be challenging, the consequences of being
unprepared to contain and respond to developing
outbreaks of novel pathogens from permafrost
could represent a serious threat for the global
economy and society, as demonstrated by Covid-
19. Therefore, it is in the mutual interests of
all nations to cooperate in the monitoring and
surveillance of novel pathogen outbreaks from
permafrost.
It is also important to acknowledge that
pathogens have been previously used to man-
ufacture and test biological weapons (mostly
by governments in relation to Anthrax-causing
B.anthracis pre- and post-World War II [43], but
also more recently in a 2001 attack via letters
in the US postal system [44]). Therefore, there
is clearly potential for groups or organisations
with malicious intent to extract and modify mi-
croorganisms frozen in permafrost for dangerous
agendas and purposes [45–50], making strong in-
ternational cooperation and leadership from the
WHO even more important in this regard.
Ultimately, tackling the climate crisis and limit-
ing global warming according to the Paris Agree-
ment will help to address the major driver be-
hind permafrost thawing and potential release
of pathogens. The risk posed by thawing per-
mafrost, on top of the myriad of threats already
posed by climate change, should inspire all na-
tions to take their commitments to reduce their
greenhouse gas emissions seriously.
Conclusion
The more that human civilisation extracts and
exposes permafrost directly or indirectly through
physical exploitation or climate change, the
greater the likelihood that novel pathogens may
be released and cause death and disease in hu-
man, animal and plant populations. Underesti-
mating the threat of novel pathogens from un-
usual sources has been shown to carry serious
consequences for all human civilisation, as demon-
strated by the Covid-19 pandemic. Although the
likelihood of a pandemic caused by pathogens in
permafrost is relatively low compared to zoonoses
(e.g., Covid-19), the risks posed by permafrost-
related pathogens must be taken seriously. Cre-
ating and implementing appropriate biosecurity
management plans in areas of greatest risk could
save many lives and livelihoods. The effectiveness
of these plans at controlling any outbreaks from
permafrost will ultimately depend on strong in-
ternational cooperation and regulation by public
health organisations and governments.
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